ECONOMIC EVALUATION OF INFLIXIMAB AND ADALIMUMAB FOR CROHN'S DISEASE

被引：0
|
作者：
Hughes, D. A. [1 ]
Kikuchi, T. [1 ]
Bodger, K. [2 ]
机构：
[1] Bangor Univ, Bangor, Gwynedd, Wales
[2] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)73358-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A59 / A59
页数：1
相关论文
共 50 条
  • [41] Adalimumab for Crohn's disease after infliximab treatment failure: a systematic review
    Da, Wei
    Zhu, Jinshui
    Wang, Long
    Lu, Yunmin
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (08) : 885 - 891
  • [42] DOSE VARIATIONS WITH ADALIMUMAB AND INFLIXIMAB IN THE TREATMENT OF CROHN'S DISEASE: A CANADIAN ASSESSMENT
    Lachaine, J.
    Beauchemin, C.
    Goyette, A.
    Martel, M. J.
    VALUE IN HEALTH, 2011, 14 (03) : A182 - A182
  • [43] A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease
    Dretzke, J.
    Edlin, R.
    Round, J.
    Connock, M.
    Hulme, C.
    Czeczot, J.
    Fry-Smith, A.
    McCabe, C.
    Meads, C.
    HEALTH TECHNOLOGY ASSESSMENT, 2011, 15 (06) : 1 - +
  • [44] Benefit of Infliximab Re-Introduction After Successive Failure of Infliximab and Adalimumab in Crohn's Disease
    Gagniere, Charlotte
    Beaugerie, Laurent
    Pariente, Benjamin
    Seksik, Philippe
    Amiot, Aurelien
    Abitbol, Vered
    Allez, Matthieu
    Cosnes, Jacques
    Sokol, Harry
    GASTROENTEROLOGY, 2014, 146 (05) : S456 - S456
  • [45] Adalimumab in Crohn's disease
    Van Assche, Gert
    Vermeire, Severine
    Rutgeerts, Paul
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (04): : 355 - 365
  • [46] Adalimumab for Crohn's disease
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (04): : 291 - 291
  • [47] Adalimumab - In Crohn's disease
    Plosker, Greg L.
    Lyseng-Williamson, Katherine A.
    BIODRUGS, 2007, 21 (02) : 125 - 132
  • [48] Efficacy of adalimumab in patients with Crohn's disease and failure to infliximab therapy: a clinical series
    Cordero Ruiz, Patricia
    Castro Marquez, Cristina
    Mendez Rufian, Vanesa
    Castro Laria, Luisa
    Caunedo Alvarez, Angel
    Romero Vazquez, Javier
    Herrerias Gutierrez, Juan Manuel
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2011, 103 (06) : 294 - 298
  • [49] Adalimumab safety in patients with Crohn's Disease and previous exposure to infliximab: CHOICE trial
    Lichuger, Simon
    Binion, David G.
    Wolf, David C.
    Present, Daniel H.
    Lomax, Kathleen G.
    Kent, Jeffrey D.
    Cardoso, Alexandra T.
    Lau, Winnie
    GASTROENTEROLOGY, 2008, 134 (04) : A489 - A489
  • [50] Efficacy and safety of infliximab versus adalimumab in the treatment of Crohn's disease: The McGill Experience
    Al-Taweel, T.
    Strohl, M.
    Kopylov, U.
    Paradis-Suprenant, L.
    Almaimany, M.
    Martel, M.
    Bitton, A.
    Afif, W.
    Bessissow, T.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S369 - S369
12345